bpc 157 human clinical trials evidence safety review BPC-157 and the Difference Between an Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded Multifunctionality and Possible Medical Application
Description
In a pilot trial of NAD+ intravenous infusion in healthy adults, subjects receiving 750 mg of NAD+ over 6 hours reported no negative symptoms at all, and there were no vital sign abnormalities or serious laboratory derangements compared to placebo

Dissolvable Strip: What Is the Difference

Some people report feeling more energetic within a few days, while others might not notice improvements for several weeks, depending on the level of deficiency

[DOI] [PMC free article] [PubMed] [Google Scholar] 6
